Email Updates

You are here

AVAC in the News

  • An excellent webinar from AVAC on deleopments in COVID-19 vaccine research is now online featuring a talk by Barney Graham, Director of US NIH Vaccine Research Centre (VRC). The talk reviews the rapid development timeline for COVID-19 vaccines, including the role played by HIV researchers and trial networks, and covers some of the recent research developments.

    August 27, 2020
    General
    i-base
  • On July 24, the European Medicines Agency (EMA) adopted a positive opinion on the dapivirine vaginal ring for use by cisgender women ages 18 and older in developing countries to reduce the risk of HIV. The ring is an important user-controlled option for women who choose not to, or are unable to, use pre-exposure prophylaxis (PrEP).

    August 18, 2020
    The BodyPro
  • Typically, it can take at least a decade to develop a new vaccine, with the shortest timeline in history being four years to develop one for mumps. As part of this process, potential vaccines go through stages of research, from preclinical work in animals to phase one clinical trials that test the safety of potential vaccines in healthy volunteers. From there, vaccine candidates move onto larger phase two and three studies that see if the vaccines are effective at preventing a given disease.

    August 5, 2020
    General
    Bhekisisa
  • Five years into tracking global pre-exposure prophylaxis (PrEP) data, the HIV advocacy organization AVAC has launched a new interactive site that allows users to visualize worldwide country-level information about PrEP use.

    August 5, 2020
    POZ
  • The US government has stepped up efforts to persuade members of minority communities to participate in clinical trials for COVID-19 vaccines, fearing that their historical suspicion of public health authorities will limit the number of volunteers.

    August 4, 2020
    General
    Financial Times
  • As the world waits with baited breath for a safe and effective vaccine to prevent SARS-CoV-2, the new coronavirus that causes COVID-19, people living with HIV are concerned that they may be excluded from clinical trials testing these vaccines.

    July 30, 2020
    General
    POZ
  • A vaginal ring that has been undergoing trials has been given approval by the European Medicines Agency to be used as an HIV prevention method among women who have tested negative.

    July 25, 2020
    The Independent
  • In 1984, scientists discovered the virus at the root of an alarming epidemic that was sickening otherwise healthy young men with aggressive cancers and rare, life-threatening pneumonias. Thirty-six years later, there still is no HIV vaccine. But instead of being a cautionary tale of scientific hubris, that unsuccessful effort is leading to even greater confidence in the search for a coronavirus vaccine, from some of the same researchers who have spent their careers seeking a cure for AIDS.

    July 14, 2020
    HIV Vaccine, General
    Washington Post
  • Researchers discussed HIV prevention research during a press conference at the AIDS 2020 meeting, highlighting the importance of involving young people and women. The event included perspectives from various researchers on successful interventions and disruptions to treatment because of the COVID-19 pandemic.

    July 8, 2020
    Healio
  • The conversation at AIDS 2020 is focusing not just on developing new technologies to fight HIV/AIDS — but also ensuring the tools that already exist realize their potential for impact. As the world falls short of 2020 targets for progress on HIV/AIDS, global health experts are highlighting the need to make testing, prevention, and treatment affordable and accessible.

    July 8, 2020
    Devex

Pages